An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
To explore how NIDDK-interested researchers can use implementation science to ensure NIDDK’s evidence-based and promising interventions reach 1) diverse populations at highest risk and/or with disparate rates for NIDDK diseases/conditions and 2) diverse practice settings (e.g., clinics, schools, places of worship, workplaces, social services agencies, and other community organizations).
Meeting Objectives
To bring together chronic disease-relevant scientists, implementation scientists from across scientific disciplines, and community and patient partners to discuss how implementation science can be used to advance health equity for NIDDK diseases/conditions
To identify research opportunities and gap areas to promote equitable implementation of evidence-based and promising interventions for NIDDK diseases/conditions for diverse populations and settings
To identify training resources, research tools, capacity building needs, and opportunities for networking and collaboration to better plan, and conduct rigorous implementation science studies to advance health equity for NIDDK diseases/conditions
Workshop Overview: Setting the Stage for the Critical Roles of Implementation Science and Health Equity in NIDDK Research
Debra Haire-Joshu, PhD, RN, MS, MA (Washington University)
9:25 a.m. – 9:50 a.m.
Keynote: Applying a Health Equity Lens to Implementation Science — An Introduction
Meghan Lane-Fall, MD, MSHP (University of Pennsylvania)
9:50 a.m. – 10:00 a.m.
Moderated Q&A
10:00 a.m. – 10:15 a.m.
Break
10:15 a.m. – 11:15 a.m.
Panel 1: Implementation Science, Health Equity and Capacity Building
Moderators: Karla Galaviz, PhD (Indiana University) and Stephanie
Fitzpatrick, PhD, FSBM (Northwell Health)
Dinushika Mohottige MD, MPH (Mount Sinai)
Rachel Shelton, ScD, MPH (Columbia University)
Natasha Williams, EdD, MPH (New York University)
Moderated Q&A (15 min)
11:15 a.m. – 12:15 p.m.
Panel 2: Importance of Community Engagement and Implementation Science in Diverse Populations and Practice Settings
Moderators: Gabriela Buccini, PhD, MSc, IBCLC (University of Nevada) and Kaleigh Mancha, LMFT (Heart and Sol)
Lilia Cervantes, MD (University of Colorado-Anschutz) and Claudia Camacho, BS (University of Colorado-Anschutz)
Sharon Herring, MD, MPH (Temple University) and Linda Kilby, PhD, RD, LDN (Philadelphia WIC Program)
Robert L. Newton, Jr., Ph.D., FSBM (Pennington Biomedical Research Center) and Levar Robinson (Fathers On A Mission)
Moderated Q&A (15 min)
12:15 p.m. – 1:30 p.m.
Lunch
1:30 p.m. – 2:30 p.m.
Breakout Sessions: Discussion of How to Integrate Implementation Science and Health Equity into Interventions (in-person and virtual)
2:30 p.m. – 3:00 p.m.
Break
3:00 p.m. – 4:00 p.m.
Breakout Session Report-back
Moderator: Shavon Artis Dickerson, DrPH, MPH (NIDDK)
Poster Session (Atrium location) and Networking (in-person and
virtual)
Day 2
9:00 a.m. – 9:05 a.m.
Welcome and Recap
Shavon Artis Dickerson, DrPH, MPH (NIDDK)
9:05 a.m. – 10:05 a.m.
Panel 3: Incorporating Community-Based Participatory Methods and Community Partnerships Across the Spectrum of Research Activities
Moderators: Jaclynn Hawkins, PhD, MSW (University of Michigan) and Julia Price, PhD (Nemours Children’s Health)
Kathryn Fantasia, MD, MSc (Boston University): “Using CoDesign to Develop Strategies to Increase Automated Insulin Delivery
System Use for Black Adults with Type 1 Diabetes”
Chung Sang Tse, MD (University of Pennsylvania): “Digital Health Technologies Decentralizing Clinical Trial Operations and Reducing Inequities for Psychosocial Care in Adults with Inflammatory Bowel Diseases”
Katharine Garrity, MS, RD (University of Michigan): “Barriers to and Facilitators of Participant Engagement in a Multi-level intervention for type 2 diabetes and food insecurity: A Qualitative Investigation”
Stella S. Yi, PhD (NYU): “A Culturally Specific Fresh Produce
Program to Improve Diet in Chinese and Mexican Communities:
Lessons Learned in Equitable Implementation”
Christine March, MD, MS (University of Pittsburgh): Barriers and
facilitators to school-partnered type 1 diabetes (T1D) interventions:
perspectives from school nurses in two states
10:05 a.m. – 10:15 a.m.
Break
10:15 a.m. – 11:15 a.m.
Breakout Session: Integrating Implementation Science and Health Equity into NIDDK Research Across Diverse Populations and Settings – Needs, Opportunities, Tools (in-person and virtual)
11:15 a.m. – 11:25 p.m.
Break
11:25 p.m. – 11:55 p.m.
Closing Panel: Future Directions for Implementation Science to Promote Equity in NIDDK Diseases & Conditions Moderator: William Cefalu, MD (NIDDK DEM Director)
James Rimmer, PhD (University of Alabama)
Donna Spiegelman, ScD (Yale University)
Heidi Brown, MD, MAS (Kaiser Permanente)
Taren Swindle, PhD (University of Arkansas for Medical
Sciences)
Abstracts for oral or poster presentations are encouraged to present dissemination and implementation research studies that promote equitable implementation of evidence-based and promising interventions for NIDDK diseases/conditions for diverse populations and settings. Abstracts from trainees and early-stage investigators are particularly encouraged.
Submitting Abstracts
All abstracts must be submitted via email to Danielle Johnikin, with “Health Equity Workshop” in the subject line. The abstract submission should be a one-page Microsoft Word document that does not exceed 250 words (not including the abstract’s title, name and affiliation of all authors, and one table or figure).
Presenters are welcome to submit abstracts previously presented in other venues, including work that has been delivered at other conferences or published within the past 2 years. If the work has been published, please include a full citation and a link to the paper.
Abstract Organization
Organize the body of the abstract as follows:
Purpose—Concisely state the objective of the study.
Methods—Describe the methods, which may include study design, setting, participants, measures, and analytic approach.
Results—Summarize the main findings in sufficient detail to support the conclusion.
Conclusions—Briefly state the conclusions and implications.
The abstract’s word count is limited to no more than 250 words.
Abstract Formatting Requirements
Please follow the instructions below to format an abstract. (Note: Submissions will not be edited for spelling or grammar and will be accepted “as is.”)
The abstract should be a Microsoft Word document with 1-inch margins, typed single space, and using Times New Roman font; a 12-point font should be used for everything except the title.
Please indicate whether you would like your abstract submission to be considered for an oral presentation only, a poster presentation only, or for either an oral or poster presentation.
The abstract’s title should be typed in Title Case using bold 16-point font and should clearly represent the nature of the investigation.
List the author’s first and last names, degree, affiliation, city, and state. If more than one author is listed, include complete information for all authors and underline the presenting author’s name.
Please indicate if the presenting author is a trainee or early stage investigator
Please ensure that the body of your abstract is the correct length (no longer than 250 words).
One table or figure may be included; however, the abstract may not be longer than one page, including the table or figure.
The abstract file name should follow this format: primary author’s LastName_FirstWordOfTitle (e.g., Zucker_Effects).
Acceptance Notifications
Applicants will be notified if their abstract has been accepted for a poster or oral presentation by approximately 06/28/2024.
Research Presentations
Oral presentations will be conducted during the workshop, with approximately 8 minutes to present and 2 minutes for questions and answers. There will also be a 1-hour session for poster presentations and networking.
Detailed instructions regarding oral and poster presentations will be provided at the time of acceptance.
All presenters must register in advance for the conference. Registration is free.
Event Logistics
Registration
Registration Closed
Registration ended
Location
Natcher Conference Center Building 45 NIH Campus Bethesda,MD20894
Webinar
This is a hybrid workshop. Virtual participation is available. For those attending via webinar, the link will be distributed via email prior to the date of the event.
